메뉴 건너뛰기




Volumn 31, Issue 9, 2013, Pages 1182-1187

Steroid-sparing effect of corticorelin acetate in peritumoral cerebral edema is associated with improvement in steroid-induced myopathy

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE;

EID: 84875982407     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.9455     Document Type: Article
Times cited : (34)

References (21)
  • 1
    • 35348967949 scopus 로고    scopus 로고
    • Medical management of brain tumor patients
    • DOI 10.1016/j.ncl.2007.07.015, PII S0733861907000813, Brain Tumors in Adults
    • Drappatz J, Schiff D, Kesari S, et al: Medical management of brain tumor patients. Neurol Clinics 25:1035-1071, 2007 (Pubitemid 47610811)
    • (2007) Neurologic Clinics , vol.25 , Issue.4 , pp. 1035-1071
    • Drappatz, J.1    Schiff, D.2    Kesari, S.3    Norden, A.D.4    Wen, P.Y.5
  • 2
    • 0023933181 scopus 로고
    • Steroid-induced CT changes in patients with recurrent malignant glioma
    • Cairncross G, Macdonald DR, Pexman JH, et al: Steroid-induced CT changes in patients with recurrent malignant glioma. Neurology 38:724-726, 1988
    • (1988) Neurology , vol.38 , pp. 724-726
    • Cairncross, G.1    Macdonald, D.R.2    Pexman, J.H.3
  • 3
    • 0001643813 scopus 로고
    • Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery
    • Galicich JH, French LA: Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery. Am Pract Dig Treat 12:169-174, 1961
    • (1961) Am Pract Dig Treat , vol.12 , pp. 169-174
    • Galicich, J.H.1    French, L.A.2
  • 4
    • 0001908046 scopus 로고
    • Use of dexamethasone in treatment of cerebral edema associated with brain tumors
    • Galicich JH, French LA, Melby JC: Use of dexamethasone in treatment of cerebral edema associated with brain tumors. Lancet 81:46-53, 1961
    • (1961) Lancet , vol.81 , pp. 46-53
    • Galicich, J.H.1    French, L.A.2    Melby, J.C.3
  • 5
    • 0036933003 scopus 로고    scopus 로고
    • Dexamethasone treatment in patients with brain metastases and primary brain tumors: Do the benefits outweigh the side-effects?
    • DOI 10.1007/s00520-001-0333-0
    • Hempen C, Weiss E, Hess CF: Dexamethasone treatment in patients with brain metastases and primary brain tumors: Do the benefits outweigh the side-effects? Support Care Cancer 10:322-328, 2002 (Pubitemid 36056287)
    • (2002) Supportive Care in Cancer , vol.10 , Issue.4 , pp. 322-328
    • Hempen, C.1    Weiss, E.2    Hess, C.F.3
  • 7
    • 0013954524 scopus 로고
    • The action of steroids and Triton X-100 upon phospholipid/cholsterol structures
    • Weissman G, Sessa G, Weissman S: The action of steroids and Triton X-100 upon phospholipid/cholsterol structures. Biochem Pharmcol 15: 1537-1551, 1966
    • (1966) Biochem Pharmcol , vol.15 , pp. 1537-1551
    • Weissman, G.1    Sessa, G.2    Weissman, S.3
  • 8
    • 0023257243 scopus 로고
    • A nonglucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage
    • Hall ED, McCall JM, Chase RL, et al: A nonglucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage. J Pharmacol Exp Ther 242:137-142, 1987 (Pubitemid 17112271)
    • (1987) Journal of Pharmacology and Experimental Therapeutics , vol.242 , Issue.1 , pp. 137-142
    • Hall, E.D.1    McCall, J.M.2    Chase, R.L.3
  • 9
    • 0025947608 scopus 로고
    • Evidence for 21-aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells
    • Audus KL, Guillot FL, Braughler JM: Evidence for 21-aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells. Free Radical Biol Med 11:361-371, 1991
    • (1991) Free Radical Biol Med , vol.11 , pp. 361-371
    • Audus, K.L.1    Guillot, F.L.2    Braughler, J.M.3
  • 10
    • 0038407615 scopus 로고    scopus 로고
    • Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists
    • Hillhouse EW, Grammatopoulos OK: Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 13:436-444, 2002
    • (2002) Trends Endocrinol Metab , vol.13 , pp. 436-444
    • Hillhouse, E.W.1    Grammatopoulos, O.K.2
  • 12
    • 0021967251 scopus 로고
    • Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications
    • Schulte HM, Chrousos GP, Gold PW, et al: Continuous administration of synthetic ovine corticotropin-releasing factor in man: Physiological and pathophysiological implications. J Clinical Investigation 75:1781-1785, 1985 (Pubitemid 15237785)
    • (1985) Journal of Clinical Investigation , vol.75 , Issue.6 , pp. 1781-1785
    • Schulte, H.M.1    Chrousos, G.P.2    Gold, P.W.3
  • 14
    • 8344241192 scopus 로고    scopus 로고
    • The management of brain edema in brain tumors
    • DOI 10.1097/01.cco.0000142076.52721.b3
    • Kaal EC, Vecht CJ: The management of brain edema in brain tumors. Curr Opin Oncol 16:593-600, 2004 (Pubitemid 39482980)
    • (2004) Current Opinion in Oncology , vol.16 , Issue.6 , pp. 593-600
    • Kaal, E.C.A.1    Vecht, C.J.2
  • 15
    • 79959582372 scopus 로고    scopus 로고
    • Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models
    • Gamez I, Ryan RP, Reid LD, et al: Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models. Cancer Chemother Pharmacol 67:1415-1422, 2011
    • (2011) Cancer Chemother Pharmacol , vol.67 , pp. 1415-1422
    • Gamez, I.1    Ryan, R.P.2    Reid, L.D.3
  • 16
    • 84875986930 scopus 로고    scopus 로고
    • Evidence of continued clinical benefit in patients who participated in an open-label, extended-use study of human corticotropin releasing factor (HCRF) in patients with cerebral edema who received HCRF for at least 6 months
    • O'Connor PC, Kroon H-A, Recht LD: Evidence of continued clinical benefit in patients who participated in an open-label, extended-use study of human corticotropin releasing factor (HCRF) in patients with cerebral edema who received HCRF for at least 6 months. Neuro-Oncology 12:iv38, 2010 (suppl 4)
    • (2010) Neuro-Oncology , vol.12 , Issue.SUPPL. 4
    • O'Connor, P.C.1    Kroon, H.-A.2    Recht, L.D.3
  • 17
    • 0014341457 scopus 로고
    • Steroid myopathy: Clinical, histologic and cytologic observations
    • Afifi AK, Bergman RA, Harvey JC: Steroid myopathy: Clinical, histologic and cytologic observations. Johns Hopkins Med J 123:158-173, 1968
    • (1968) Johns Hopkins Med J , vol.123 , pp. 158-173
    • Afifi, A.K.1    Bergman, R.A.2    Harvey, J.C.3
  • 20
    • 0025800020 scopus 로고
    • Steroid-induced weakness in patients with primary brain tumors
    • Dropcho EJ, Soong S-J: Steroid-induced weakness in patients with primary brain tumors. Neurology 41:1235-1239, 1991
    • (1991) Neurology , vol.41 , pp. 1235-1239
    • Dropcho, E.J.1    Soong, S.-J.2
  • 21
    • 0002714896 scopus 로고
    • Endocrine myopathies
    • Engel AG, Banker BQ (eds) New York, NY, McGraw-Hill
    • Ruff RL: Endocrine myopathies, in Engel AG, Banker BQ (eds): Myology: Basic and clinical. New York, NY, McGraw-Hill, 1986, pp 1871-1979
    • (1986) Myology: Basic and Clinical , pp. 1871-1979
    • Ruff, R.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.